Concord Biotech

Concord Biotech Ltd Half Yearly Results

NSEBSE

₹1,454.9

(-1.01%)

Nov 4, 2025|12:00:00 AM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Mar-2025	Sept-2024	Mar-2024	Sept-2023	Mar-2023
Gross Sales	674.1	525.98	559.77	457.17	513.27
Excise Duty	0	0	0	0	0
Net Sales	674.1	525.98	559.77	457.17	513.27
Other Operating Income	0	0	0	0	0
Other Income	24.11	20.33	19.82	17.33	17.73
Total Income	698.22	546.32	579.59	474.5	531
Total Expenditure	385.45	309.63	319.55	265.83	272.53
PBIDT	312.77	236.69	260.04	208.67	258.47
Interest	0.19	0.34	0.96	1.59	2.36
PBDT	312.58	236.35	259.08	207.08	256.11
Depreciation	27.88	26.49	27.26	26.34	27.95
Minority Interest Before NP	0	0	0	0	0
Tax	65.51	53.45	55.78	44.06	57.56
Deferred Tax	2.88	1.07	3.46	1.17	1.73
Reported Profit After Tax	216.31	155.33	172.59	135.51	168.86
Minority Interest After NP	0	0	0	0	0
Net Profit after Minority Interest	216.31	155.33	172.59	135.51	168.86
Extra-ordinary Items	0	0	0	0	0
Adjusted Profit After Extra-ordinary item	216.31	155.33	172.59	135.51	168.86
EPS (Unit Curr.)	20.68	14.85	16.5	12.95	16.14
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	0	0	0	0	0
Equity	10.46	10.46	10.46	10.46	10.46
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	46.39	44.99	46.45	45.64	50.35
PBDTM(%)	-	-	-	-	-
PATM(%)	32.08	29.53	30.83	29.64	32.89